Rare diseases
Investigational molecules
Locations
Rcsi House, 121 Saint Stephen's Green, D02 H903 Dublin, Ireland
Research activity includes early-stage HER2-positive breast cancer, hormone receptor-positive and HER2-negative breast cancer with low recurrence score, and node-positive breast cancer with 1-3 positive nodes. The funded trials focus on neoadjuvant therapy, endocrine therapy, and decisions about the role of chemotherapy in recurrence risk.
Clinical interest also extends to treatment selection guided by tumour biology and risk of relapse.
Cancer Trials Ireland runs clinical trials in conditions such as Prostate cancer, Squamous cell carcinoma, Breast cancer, Serous cystadenocarcinoma ovary, among others.
Clinical trials run by this sponsor – those enrolling participants first.
IrelandStudy Comparing Two Cisplatin Dosing Schedules with Radiation for Patients with Advanced Head and Neck Cancer
IrelandStudy on Darolutamide with Standard Therapy for Patients with High-Risk Localized Prostate Cancer
IrelandStudy on the Effects of Chemotherapy and Endocrine Therapy in Patients with Hormone Receptor-Positive, HER2-Negative Breast Cancer Using Tamoxifen and Anastrozole
IrelandStudy of Paclitaxel, Carboplatin and Letrozole Treatment Compared to Letrozole Alone in Patients with Stage II-IV Low-Grade Serous Ovarian or Peritoneal Cancer
IrelandStudy on the Effectiveness and Safety of Isatuximab, Lenalidomide, Bortezomib, and Dexamethasone for Patients with Newly Diagnosed Multiple Myeloma
DenmarkStudy on Enzalutamide and Drug Combination for High-Risk Localized Prostate Cancer Patients
AustriaStudy of trametinib and hydroxychloroquine in patients with metastatic pancreatic cancer that has not responded to previous treatment
IrelandStudy of enzalutamide compared to bicalutamide and flutamide in first-line treatment for patients with metastatic prostate cancer
IrelandStudy Comparing High Dose Interferon, Ipilimumab, and Pembrolizumab for Patients with High Risk Resected Melanoma
IrelandIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
